Innovations in infectious disease testing: Leveraging COVID-19 pandemic technologies for the future

Innovations in infectious disease testing have improved our abilities to detect and understand the microbial world. The 2019 novel coronavirus infectious disease (COVID-19) pandemic introduced new innovations including non-prescription “over the counter” infectious disease tests, mass spectrometry-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Nam K., Albahra, Samer, Rashidi, Hooman, May, Larissa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Canadian Society of Clinical Chemists. Published by Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735816/
https://www.ncbi.nlm.nih.gov/pubmed/34998789
http://dx.doi.org/10.1016/j.clinbiochem.2021.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735816/
https://www.ncbi.nlm.nih.gov/pubmed/34998789
http://dx.doi.org/10.1016/j.clinbiochem.2021.12.011

Ejemplares similares